Jun 15, 2021 Press Releases
This virtual event on June 24, featuring entertainment from Sheryl Crow, will raise awareness and funds to find treatments and cures for blinding diseases.
Jun 4, 2021 Press Releases
The Spring Virtual VisionWalk on June 12th will raise awareness and fund research finding treatments and cures for blinding retinal diseases.
May 21, 2021 Industry News
The bill would provide loans to therapy developers ready to launch clinical trials for a broad range of conditions including eye diseases.
May 21, 2021 Press Releases
Legislation provides innovative financing for clinical trials stalled by COVID-19 pandemic.
May 20, 2021 Press Releases
The free webinar for eye care professionals, on June 21, will feature some of the intriguing and innovative research efforts underway for inherited retinal diseases and AMD.
An overview of the Foundation’s no-cost genetic testing program will also be presented.
May 18, 2021 The Foundation in the News
Uses novel, mutation agnostic optogenetics approach to restore vision in underserved forms of blindness. Company backed by leading life science investors including Octagon Capital, Samsara BioCapital and Casdin Capital, along with founding investors Atlas Venture, Mission BioCapital and Foundation Fighting Blindness.
May 6, 2021 Insights Forum
The Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the inherited retinal disease community. The call took place on April 29, 2021.
Apr 29, 2021 Press Releases
The project will help identify outcome measures for future clinical trials of potential USH1F therapies.
Apr 27, 2021 Press Releases
Dr. Gelfman brings over twenty years of successful ophthalmic research and development experience to the Foundation executive team.
Mar 23, 2021 Press Releases
The program honors Lulie Gund and her legacy and commitment to the Foundation’s Chapter community.
Mar 2, 2021 Press Releases
Course Title: Clinical Trials of Emerging Therapies for Retinal Degeneration Patients: Hope and Opportunities